SN1
SHORT NOTE
5M
★ High-yield
Define gout. Describe its biochemical basis, causes and treatment.
Definition
Gout = a disorder of purine metabolism characterised by hyperuricaemia and deposition of monosodium urate crystals in joints and soft tissues.
- Hyperuricaemia — serum urate above 7 mg/dL in men, 6 mg/dL in women
- Most people with hyperuricaemia never develop gout; it is necessary but not sufficient
Classification and Causes
| Type | Mechanism | Causes |
|---|---|---|
| Primary — overproduction (10%) | ↑ De novo purine synthesis | PRPP synthetase over-activity; partial HGPRT deficiency; glucose-6-phosphatase deficiency |
| Primary — underexcretion (90%) | ↓ Renal urate clearance | Idiopathic; genetic transporter variants |
| Secondary — overproduction | Excess cell turnover | Leukaemia, lymphoma, psoriasis, haemolysis, tumour lysis syndrome |
| Secondary — underexcretion | Competition or renal disease | Thiazides, low-dose aspirin, alcohol, lactic acidosis, ketosis, chronic kidney disease, lead |
WHY Crystals Form and Where
- Urate is least soluble at low temperature and low pH
- Hence the classical first attack in the first metatarsophalangeal joint (podagra) — the coolest, most peripheral joint
- Crystals are needle-shaped and negatively birefringent under polarised light — the diagnostic finding
- They are phagocytosed by neutrophils → inflammasome activation → IL-1β → acute inflammation
Clinical Features
- Acute gouty arthritis — sudden, exquisitely painful, red, swollen joint, often at night
- Intercritical period — symptom-free between attacks
- Chronic tophaceous gout — tophi in the ear cartilage, olecranon bursa and tendons; joint destruction
- Renal — uric acid stones (radiolucent), urate nephropathy
- Associated with the metabolic syndrome, hypertension and cardiovascular disease
Treatment
| Phase | Drug | Mechanism |
|---|---|---|
| Acute attack | NSAIDs, colchicine, steroids | Colchicine binds tubulin → blocks neutrophil migration |
| Long term — underexcretors | Probenecid (uricosuric) | ↑ Renal urate excretion |
| Long term — overproducers | Allopurinol, febuxostat | Inhibit xanthine oxidase |
| Refractory | Rasburicase (recombinant uricase) | Converts urate to soluble allantoin |
Applied Aspects
- Never start or stop allopurinol during an acute attack — any sudden change in urate level can precipitate or prolong it
- Allopurinol with azathioprine or 6-mercaptopurine is dangerous — xanthine oxidase normally inactivates them, so the dose must be cut drastically
- Tumour lysis syndrome — massive cell breakdown after chemotherapy → hyperuricaemia, hyperkalaemia, hyperphosphataemia and renal failure. Prevented by hydration and allopurinol or rasburicase
- Low-dose aspirin raises urate (it competes for the tubular transporter) while high doses are uricosuric
All questions in Nucleotide Metabolism & Molecular Biology
- Q1Describe the de novo synthesis of purine nucleotides with its regulation. Explain the salvage pathway and the degradation of purines. ★
- Q2Describe the synthesis and degradation of pyrimidine nucleotides. Compare them with purines and add a note on orotic aciduria. ★
- Q3Describe the process of DNA replication with the enzymes involved. Add a note on telomeres and the inhibitors of replication. ★
- Q4Describe transcription and the post-transcriptional processing of mRNA. Compare it with replication. ★
- Q5Describe the process of translation. Explain the genetic code and the inhibitors of protein synthesis. ★
- SN1Define gout. Describe its biochemical basis, causes and treatment. ★
- SN2Describe the salvage pathway of purines. Add a note on Lesch–Nyhan syndrome. ★
- SN3Describe the principle, steps and applications of the polymerase chain reaction. ★
- SN4Classify mutations with examples. Add a note on DNA repair. ★
- SN5Describe the tools of recombinant DNA technology and its medical applications. ★
- SN6Describe the genetic code with its properties. Add a note on the wobble hypothesis.
- SN7Describe the structure of DNA. Add a note on its denaturation and melting temperature. ★